1.2% Above Target

Wall Street's consensus price target for MLAB is $94, -1.2% from its current price of $95.1. The below-market target from 8 analysts suggests limited near-term appreciation.

MLAB has a consensus rating of "Hold" based on 8 Wall Street analysts. The rating breakdown is mixed, with 5 Hold ratings making up the largest segment. The consensus 12-month price target of $94 implies -1.2% downside from current levels.

With a forward P/E of 10.4909x, MLAB trades at a relatively low valuation. The consensus target of $94 implies -1.2% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $94 for MLAB, while the most conservative target is $94. The consensus of $94 represents the median expectation. Our quantitative valuation model projects a bull case target of $105 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

MLAB is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 5 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month MLAB stock forecast based on 8 Wall Street analysts shows a consensus price target of $94, with estimates ranging from $94 (bear case) to $94 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $80, with bear/bull scenarios of $50/$105.

Our quantitative valuation model calculates MLAB's fair value at $80 (base case), with a bear case of $50 and bull case of $105. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.

MLAB trades at a forward P/E ratio of 10.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 78.6x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on MLAB, with 0 Sell ratings and a price target of $94 (-1.2% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

MLAB analyst price targets range from $94 to $94, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $94 consensus represents the middle ground. Our model's $50-$105 range provides an independent fundamental perspective.